Difficulty: Medium
Average Score: 67%
Practice
Which of the following is/are true about prenatal pertussis vaccination:
Correct answer
B
Rationale
Infection control in nursing is crucial for preventing the spread of diseases, especially in vulnerable populations like pregnant women and newborns. Pertussis, or whooping cough, is a highly contagious respiratory disease that can be severe for infants. Prenatal pertussis vaccination is recommended to provide passive immunity to newborns until they are old enough to be vaccinated themselves.
Option B, "Vaccine should be offered in every pregnancy," is correct because giving the vaccine during each pregnancy maximizes protection for each newborn. This strategy ensures that maternal antibodies are transferred to the fetus, offering protection during the vulnerable early months of life.
Option A, "Vaccination should be offered starting from 26 weeks of gestation," is incorrect because the recommendation is to administer the vaccine between 27-36 weeks of gestation to optimize transfer of antibodies to the fetus.
Option C, "It should not be offered after 32 weeks of pregnancy as it is unlikely to offer any protection," is incorrect because vaccination can still provide some protection even if given later in pregnancy, although earlier administration is preferred.
Option D, "Both Boostrix and Repevax are suitable for use in the prenatal program," is incorrect because only Boostrix is recommended for prenatal use, not Repevax.
Educationally, understanding the timing and choice of vaccines in prenatal care is essential for nurses to provide evidence-based care to pregnant women. By knowing the correct recommendations for pertussis vaccination, nurses can help protect both the mother and her newborn from this preventable disease.
Option B, "Vaccine should be offered in every pregnancy," is correct because giving the vaccine during each pregnancy maximizes protection for each newborn. This strategy ensures that maternal antibodies are transferred to the fetus, offering protection during the vulnerable early months of life.
Option A, "Vaccination should be offered starting from 26 weeks of gestation," is incorrect because the recommendation is to administer the vaccine between 27-36 weeks of gestation to optimize transfer of antibodies to the fetus.
Option C, "It should not be offered after 32 weeks of pregnancy as it is unlikely to offer any protection," is incorrect because vaccination can still provide some protection even if given later in pregnancy, although earlier administration is preferred.
Option D, "Both Boostrix and Repevax are suitable for use in the prenatal program," is incorrect because only Boostrix is recommended for prenatal use, not Repevax.
Educationally, understanding the timing and choice of vaccines in prenatal care is essential for nurses to provide evidence-based care to pregnant women. By knowing the correct recommendations for pertussis vaccination, nurses can help protect both the mother and her newborn from this preventable disease.